Ramos, José A.

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease

Lastres-Becker, I., Molina-Holgado, F., Ramos, J. A., Mechoulam, R., & Fernández-Ruiz, J. (2005) · Neurobiology of Disease

Cannabis and Cannabinoid ResearchParkinson's Disease Mechanisms and Treatments

Cited by 407

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties

García-Arencibia, M., González, S., de Lago, E., Ramos, J. A., Mechoulam, R., & Fernández-Ruiz, J. (2007) · Brain Research

Cannabis and Cannabinoid ResearchParkinson's Disease Mechanisms and Treatments

Cited by 320

Cannabidiol reduced the striatal atrophy caused 3‐nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1and adenosine A2Areceptors

Sagredo, O., Ramos, J. A., Decio, A., Mechoulam, R., & Fernández‐Ruiz, J. (2007) · European Journal of Neuroscience

Cannabis and Cannabinoid ResearchParkinson's Disease Mechanisms and Treatments

Cited by 147

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease

Sagredo, O., Pazos, M. R., Satta, V., Ramos, J. A., Pertwee, R. G., & Fernández‐Ruiz, J. (2011) · Journal of Neuroscience Research

Cannabis and Cannabinoid ResearchGenetic Neurodegenerative Diseases

Cited by 105

Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse

González, S., Valenti, M., de Miguel, R., Fezza, F., Fernández‐Ruiz, J., Di Marzo, V., & Ramos, J. A. (2004) · British Journal of Pharmacology

Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 79